Work

Dynamic monitoring of circulating tumor DNA next-generation gene sequencing as a predictive biomarker of response and progression-free survival after pembrolizumab monotherapy in patients with advanced NSCLC.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.3040

Authors: Charu Aggarwal, Jeffrey C. Thompson, Austin Chien, Katie Quinn, Martina Lefterova, Rebecca Nagy, Stephanie Yee, Christine Agnes Ciunci, Evan W. Alley, Joshua Bauml, Roger B. Cohen, Corey J. Langer, Erica L. Carpenter

Institutions: University of Pennsylvania, Abramson Cancer Center, University of Pennsylvania Health System, Guardant (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946869799

Cites:

Cited by: 4

Related to: 10